CAR-T Meeting 2024 | Targeting BAFF-R with CAR-Ts to treat MCL
Mike Barnkob
• 15 Feb 2024
Mike Barnkob, MD, PhD, Odense University Hospital, Odense, Denmark, shares insights into the development of BAFF-receptor (BAFF-R)-specific CARs, which were investigated for the treatment of mantle cell lymphoma (MCL). While these CARs were able to kill primary MCL cells, relapse did occur, and Dr Barnkob highlights possible escape mechanisms. This interview took place at the EBMT-EHA 6th European CAR T-cell Meeting in Valencia, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Consultancy fees: Kite/Gilead, Roche
